Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.

March 11, 2019March 11, 2019

Investigational Therapy ATYR1923 May Relieve Lung Inflammation, Preclinical Data Show

News

The investigational therapy ATYR1923 for pulmonary sarcoidosis may help decrease lung inflammation by halting the infiltration of immune cells called neutrophils into the lungs, according to a preclinical study ... Read more

February 18, 2019February 18, 2019

Familial Sarcoidosis Prevalent in Certain Populations Worldwide, Review Suggests

News

A literature review of research performed in specific populations from countries worldwide estimated a heritability of 60 to 70 percent for familial sarcoidosis, a study has found. The study ... Read more

January 7, 2019January 7, 2019

Impaired Lung Function Linked to Higher Risk of Dementia, Mild Cognitive Decline Later in Life

News

Middle-aged adults with impaired lung function, such as people with sarcoidosis, are at higher risk of dementia and mild cognitive impairment, according to a long-term follow-up study. The study, ... Read more

October 25, 2018October 25, 2018

Burden of Cardiac Arrhythmias Increasing in Sarcoidosis Patients, US Study Reports

News

Cardiac arrhythmias are increasing among sarcoidosis patients, and they are linked with higher hospital admission and mortality rates, a U.S. patient population study finds. These results, published in the ... Read more

October 2, 2018October 2, 2018

Phase 1/2 Trial to Test aTyr Pharma’s ATYR1923 in Pulmonary Sarcoidosis Patients

News

aTyr Pharma, which developing therapies to modulate immune pathways involved in lung diseases, has announced an upcoming Phase 1b/2a study to test their lead therapy ATYR1923 in patients with pulmonary ... Read more

August 7, 2018August 7, 2018

Blood Levels of 2 microRNAs May Help Diagnose Cardiac Sarcoidosis, Study Suggests

News

The levels of two blood-circulating microRNAs, called microRNA-126 and microRNA-223, may work as new biomarkers for cardiac sarcoidosis, according to researchers. Their small study, “Serum microRNA-126 and -223 as ... Read more

March 15, 2018March 15, 2018

Common Skin Bacteria May Trigger Granuloma Formation in Sarcoidosis, Study Suggests

News

Infection from the bacteria Propionibacterium acnes is found frequently and at high rates in the lymph nodes of sarcoidosis patients and may contribute to the formation of granulomas, a small study ... Read more

March 1, 2018March 1, 2018

Isolated Cardiac Sarcoidosis May Be Rarer than Previously Suggested, Small Study Says

News

A small study of a group of patients in Canada who were showing the first signs of sarcoidosis suggests that isolated cardiac sarcoidosis, which refers to cardiac involvement without the ... Read more

January 11, 2018January 11, 2018

First Total-body PET Scanner Promises to Increase Sensitivity of Diagnosis and Treatment of Sarcoidosis, Other Diseases

News

Researchers are developing a new positron emission tomography (PET) scanner capable of imaging the whole body that promises to significantly increase imaging sensitivity, advancing the technology for how diseases ... Read more

January 4, 2018January 4, 2018

Male Sarcoidosis Patients, Those on Immunosuppressive Agents Face Higher Risk for Severe Infections

News

Male sarcoidosis patients and those who use immunosuppressive agents — particularly Cytoxan (cyclophosphamide) — are more likely to get severe infections than women with the disease and those who ... Read more

Pin It on Pinterest